Canadian Hematology Today https://canadianhematologytoday.com/ en-US Tue, 03 Feb 2026 19:01:24 +0000 OJS 3.3.0.13 http://blogs.law.harvard.edu/tech/rss 60 Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options https://canadianhematologytoday.com/article/view/5-s01-Anglin_et_al <p>Relapsed and refractory (R/R) multiple myeloma presents increasingly complex therapeutic decisions. Clinicians must not only weigh efficacy and tolerability but consider how today’s treatment decisions will affect future options. In a roundtable discussion, myeloma experts discuss practical approaches to sequencing therapies across diverse patient scenarios.</p> Peter Anglin, MD, MBA, FRCPC, Paola Neri, MD, PhD, Joshua Richter, MD, FACP , Darrell White, MD, MSc, FRCPC, FACP Copyright (c) 2026 Canadian Hematology Today https://creativecommons.org/licenses/by-nc-nd/4.0 https://canadianhematologytoday.com/article/view/5-s01-Anglin_et_al Tue, 03 Feb 2026 00:00:00 +0000